Atrás
41
Rango del Día
$517.81
$537.00
Rango de 52 Semanas
$266.98
$548.12
Volumen
507,272
Promedio 50D / 200D
$491.10
/
$415.89
Cierre Anterior
$524.28
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 17.1 | 0.4 |
| P/B | 3.2 | 2.9 |
| ROE % | 19.7 | 3.8 |
| Net Margin % | 41.9 | 3.9 |
| Rev Growth 5Y % | 17.2 | 10.0 |
| D/E | 0.0 | 0.2 |
Puntos Clave
Revenue grew 17.22% annually over 5 years — strong growth
ROE of 19.71% — decent returns on equity
Net margin of 41.94% shows strong profitability
Debt/Equity of 0.00 — conservative balance sheet
Generating 1.04B in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 6.61%
Crecimiento
Revenue Growth (5Y)
17.22%
Revenue (1Y)10.61%
Earnings (1Y)11.68%
FCF Growth (3Y)17.99%
Calidad
Return on Equity
19.71%
ROIC15.77%
Net Margin41.94%
Op. Margin46.89%
Seguridad
Debt / Equity
0.00
Current Ratio6.60
Interest Coverage76.54
Valoración
P/E Ratio
17.12
P/B Ratio3.22
EV/EBITDA14.26
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 10.61% | Revenue Growth (3Y) | 16.94% |
| Earnings Growth (1Y) | 11.68% | Earnings Growth (3Y) | 16.42% |
| Revenue Growth (5Y) | 17.22% | Earnings Growth (5Y) | 29.42% |
| Profitability | |||
| Revenue (TTM) | 3.18B | Net Income (TTM) | 1.33B |
| ROE | 19.71% | ROA | 16.94% |
| Gross Margin | 87.92% | Operating Margin | 46.89% |
| Net Margin | 41.94% | Free Cash Flow (TTM) | 1.04B |
| ROIC | 15.77% | FCF Growth (3Y) | 17.99% |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 6.60 |
| Interest Coverage | 76.54 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 17.12 | P/B Ratio | 3.22 |
| P/S Ratio | 7.18 | PEG Ratio | 1.16 |
| EV/EBITDA | 14.26 | Dividend Yield | 0.00% |
| Market Cap | 22.84B | Enterprise Value | 21.29B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.18B | 2.88B | 2.33B | 1.94B | 1.69B |
| Net Income | 1.33B | 1.20B | 984.80M | 727.30M | 475.80M |
| EPS (Diluted) | 27.86 | 24.64 | 19.81 | 15.00 | 10.06 |
| Gross Profit | 2.80B | 2.57B | 2.07B | 1.79B | 1.56B |
| Operating Income | 1.49B | 1.38B | 1.18B | 979.70M | 555.90M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 7.88B | 7.36B | 7.17B | 6.04B | 5.17B |
| Total Liabilities | 783.80M | 920.00M | 1.18B | 1.25B | 1.21B |
| Shareholders' Equity | 7.10B | 6.44B | 5.98B | 4.80B | 3.96B |
| Total Debt | 0.0 | 300.00M | 700.00M | 800.00M | 800.00M |
| Cash & Equivalents | 1.56B | 1.70B | 1.21B | 961.20M | 894.80M |
| Current Assets | 3.70B | 3.87B | 3.55B | 3.38B | 2.32B |
| Current Liabilities | 560.60M | 738.10M | 804.40M | 343.20M | 305.40M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Balanced Risk
#103 of 148
Actividad Reciente
Entró
Balanced Risk
Mar 24, 2026